Increase use of independent healthcare capacity
Reform UK · what the evidence says
An independent, source-checked look at Reform UK’s policy “Increase use of independent healthcare capacity” — what it would actually do across the things that affect your life. Every claim below quotes the source behind it. How this works.
Tax & the money you keep — Helps
minor · moderate confidence
A 20% tax relief on private healthcare and insurance would cut the tax bill for households that use private care, leaving more money in their pockets — but only those who can afford private healthcare or insurance in the first place would benefit, so the gain is concentrated among higher earners.
The evidence
- The policy offers a 20% tax relief on all private healthcare spending and insurance premiums. — reformparty.uk (manifesto) — “offer tax relief of 20% on all private healthcare and insurance”
- Currently, direct payments for individual private treatments are not tax-deductible, so this relief represents a new financial benefit for those who pay out of pocket. — crmoxford.co.uk (media) — “Direct payments for individual private treatments are not currently tax-deductible.”
- Employer-provided private medical insurance is currently taxed as a benefit in kind, with employees paying income tax at their marginal rate (20%, 40%, or 45%) and employers paying Class 1A NICs at 13.8%. — crmoxford.co.uk (media) — “employees pay income tax on its value (at 20%, 40%, or 45% depending on their tax band), and employers pay Class 1A National Insurance Contributions (NICs) at 13.8% on the benefit's value.”
- Expanding tax relief for private medical insurance could reduce NHS waiting lists, based on past evidence that withdrawing such relief increased them. — researchbriefings.files.parliament.uk (government) — “When a previous tax relief for PMI for over-60s was abolished in 1997, one insurer, PPP healthcare, estimated it would increase NHS waiting lists by over 100,000”
- Those with private medical insurance are less likely to support increases in public health spending, suggesting the relief could reinforce a divide between those who benefit from the tax break and those reliant on the NHS. — ifs.org.uk (institutional) — “the IFS also found that those with PMI are less likely to support increases in public health spending, even when accounting for other characteristics.”
Biggest unknown: The scale of take-up — and therefore the size of the household gain — depends heavily on how many people actually purchase private healthcare or insurance once the relief is in place, which is uncertain.
Our reading: The policy's direct O11 effect is straightforward: a 20% tax relief on private healthcare spending and insurance premiums reduces the tax burden for households that incur those costs. Currently, out-of-pocket private treatment costs yield no tax deduction (E7), and employer-provided PMI is taxed as a benefit in kind at the employee's marginal rate (E6). The relief changes both, meaning households paying for private care keep more of their money. The gain is real but narrowly distributed: only those who can afford private healthcare or insurance benefit, and given the cost of private care, this population skews toward higher earners and more affluent areas. The magnitude is therefore minor at population scale — most households do not currently purchase private healthcare — but material for the subset that does or would. The E8 evidence on the 1997 PMI relief abolition suggests the elasticity of take-up to tax incentives exists, supporting some incremental uptake and therefore some incremental O11 gain, though the precise scale is uncertain. The distributional skew means the policy improves O11 for a relatively affluent minority rather than the median household. Under the O11 rubric, which asks who gains and who loses on money-in-pocket, this registers as a real but minor improvement concentrated at the upper end of the income distribution.
Public finances & the next generation — Hurts
moderate · moderate confidence
Offering 20% tax relief on all private healthcare and insurance reduces tax revenues with no stated funding mechanism, adding to the fiscal gap. Historical evidence from a similar policy suggests the cost is real but the scale is uncertain.
The evidence
- The policy offers 20% tax relief on all private healthcare and insurance with no stated funding mechanism or costing. — reformparty.uk (manifesto) — “offer tax relief of 20% on all private healthcare and insurance”
- Currently, direct payments for individual private treatments are not tax-deductible, meaning this relief would be a new fiscal commitment. — crmoxford.co.uk (media) — “Direct payments for individual private treatments are not currently tax-deductible.”
- A historical precedent suggests that even a narrower PMI tax relief (for over-60s only, abolished 1997) had an estimated Treasury cost, with predictions varying widely. — researchbriefings.files.parliament.uk (government) — “predictions varied widely”
- Health and social care spending pressures are already growing sharply, with projections it could reach 49% of day-to-day public service spending by end of the decade. — theguardian.com (media) — “health and social care could account for 49% of all day-to-day public service spending by the end of the decade, up from 34% in 2009-10”
Biggest unknown: The total Exchequer cost depends heavily on uptake of private healthcare and insurance, which is uncosted in the policy and could range widely.
Our reading: The core fiscal question for O12 is whether this policy is funded or unfunded, and whether any borrowing finances productive investment or consumption. The policy text commits to a 20% tax relief on all private healthcare and insurance but provides no costing, no offsetting measure, and no funding source. This is an unfunded tax relief that would reduce Exchequer revenues. The current baseline is that direct private healthcare payments attract no tax deduction, so this would be a new and potentially wide-ranging fiscal commitment. The historical precedent (the PMI relief for over-60s abolished in 1997) shows that even a narrowly targeted relief had measurable Treasury costs, albeit with wide variance in estimates. Unlike borrowing to invest in productive public infrastructure — which might improve long-run fiscal sustainability — a tax relief on private healthcare consumption does not obviously raise future economic capacity or public sector productivity. It primarily subsidises private consumption choices. On the debt-path criteria for O12, an unfunded tax relief that widens the fiscal gap without a credible productivity or revenue offset worsens public finance sustainability in both the near and medium term. The growing baseline pressure on health and social care spending (projected to consume nearly half of day-to-day public service spending) makes any additional unfunded commitment more fiscally damaging. Confidence is moderate rather than high because the total Exchequer cost is genuinely uncertain — uptake of private healthcare tax relief is hard to forecast — but the direction is clear: revenues fall, the gap widens, and no offsetting mechanism is stated.
Inequality & fair shares — Hurts
moderate · moderate confidence
A 20% tax relief on private healthcare mainly benefits people who can already afford it, concentrating gains among higher earners while the risk of NHS staff and resource drain could leave those who rely solely on the NHS worse off. The gap between rich and poor in health access is likely to widen.
The evidence
- The policy offers 20% tax relief on all private healthcare and insurance. — reformparty.uk (manifesto) — “offer tax relief of 20% on all private healthcare and insurance”
- Direct payments for individual private treatments are not currently tax-deductible, so this relief is a new benefit to those who pay for private care out of pocket. — crmoxford.co.uk (media) — “Direct payments for individual private treatments are not currently tax-deductible.”
- Employer-provided private medical insurance is already taxed as a benefit-in-kind at the recipient's marginal rate, meaning higher earners already pay more but benefit more from any relief. — crmoxford.co.uk (media) — “employees pay income tax on its value (at 20%, 40%, or 45% depending on their tax band)”
- The Health Foundation warns that if independent sector care expands, access improvements could be concentrated in more affluent areas rather than poorer ones. — vertexaisearch.cloud.google.com (media) — “access for people in more affluent areas could improve disproportionately compared to those in poorer areas”
- Analysts including the Nuffield Trust and BMA warn that such policies could divert finite NHS staff and resources to the private sector. — bmj.com (media) — “potential for such policies to divert finite staff and resources from the NHS to the private sector”
- Critics argue this would create a two-tier system where those who can afford private care receive faster and better services while NHS users face a potentially under-resourced service. — keepournhspublic.com (media) — “those who can afford private care, especially with tax incentives, receive faster access and potentially better services, while the NHS, potentially under-resourced and facing staff shortages, provides an inferior servic…”
- The IFS found that those with private medical insurance are less likely to support increases in public health spending. — ifs.org.uk (institutional) — “those with PMI are less likely to support increases in public health spending, even when accounting for other characteristics”
Biggest unknown: Whether any NHS waiting-list relief from extra private capacity would be large enough to offset the regressive distributional tilt of the tax subsidy and the workforce-diversion risk.
Our reading: The core distributional question is: who gains and who pays? The tax relief accrues to people who can afford to purchase private healthcare or insurance — by definition, a more affluent group. Higher-rate taxpayers gain proportionally more from any income-tax relief. Those who cannot afford private care receive no direct benefit from the relief itself. On the costs side, credible institutional sources (Nuffield Trust, BMA, Health Foundation) project that expanding the private sector risks drawing NHS staff away, potentially degrading care for those entirely dependent on the NHS. The Health Foundation specifically flags that capacity gains in the independent sector tend to favour more affluent areas. The IFS evidence adds a political-economy dimension: private insurance uptake is associated with reduced public support for NHS spending, which could over time erode the political coalition sustaining universal provision. The one channel through which inequality might narrow is NHS waiting-list relief — if private capacity genuinely frees up NHS slots for those who cannot pay, the less well-off could benefit indirectly. But the evidence on this is contested: the Health Foundation, Nuffield Trust, BMA, and IPPR all argue that independent sector expansion does not reliably increase overall system capacity, and focuses on profitable low-complexity cases. Absent a strong counterfactual mechanism for the poorest to gain, the preponderance of cited evidence points toward a widening gap in health-service access, which is a direct inequality indicator. Confidence is moderate rather than high because the magnitude of workforce diversion and of NHS waiting-list spillover remains genuinely uncertain.
Healthcare — Mixed picture
moderate · moderate confidence
Tax relief on private healthcare could help some patients get treated faster and take pressure off NHS waiting lists, but credible health analysts warn it may also pull staff away from the NHS and widen the gap between those who can afford private care and those who cannot.
The evidence
- The policy proposes 20% tax relief on private healthcare and insurance to harness independent and not-for-profit provision and relieve pressure on the NHS. — reformparty.uk (manifesto) — “offer tax relief of 20% on all private healthcare and insurance, aiming to relieve pressure on the NHS and improve care for all”
- Patients treated in independent facilities already wait significantly less than those in NHS hospitals. — ey.com (media) — “Patients treated in independent facilities experienced shorter waiting times, averaging around 10.6 weeks in Q1 2025, compared to approximately 17.6 weeks in NHS hospitals”
- The independent sector already delivers a substantial share of NHS activity in some specialties. — vertexaisearch.cloud.google.com (media) — “delivering 18.9% and 23.6% of all NHS activity in these areas respectively”
- Privately funded elective activity grew but remains a small share of total elective activity and has not consistently offset NHS shortfalls. — vertexaisearch.cloud.google.com (media) — “privately funded elective inpatient activity grew by 10.2% between 2019/20 and 2022/23, it still constitutes a small proportion (8.3%) of total elective activity, and overall NHS-funded treatment volumes have not consist…”
- The independent sector tends to focus on less complex, profitable cases and often lacks facilities for complex care needs. — vertexaisearch.cloud.google.com (media) — “The independent sector typically focuses on profitable, less complex cases, often lacking the broader facilities (like intensive care units) to treat patients with complex care needs”
- Analysts including the Nuffield Trust and BMA warn that such policies risk diverting finite NHS staff to the private sector. — bmj.com (media) — “A significant concern raised by analysts like the Nuffield Trust and the British Medical Association (BMA) is the potential for such policies to divert finite staff and resources from the NHS to the private sector”
- There is evidence of NHS staff already moving to the private sector, which could worsen NHS staffing shortages. — hellorayo.co.uk (media) — “There is evidence of NHS staff moving to the private sector, sometimes for better pay or working conditions, which could exacerbate existing NHS staffing shortages”
- The Health Foundation warns that if independent sector care expands more than NHS care, access improvements could favour more affluent areas disproportionately. — vertexaisearch.cloud.google.com (media) — “if independent sector care expands more than NHS-provided care, access for people in more affluent areas could improve disproportionately compared to those in poorer areas”
- The IFS found those with private medical insurance are less likely to support increases in public health spending. — ifs.org.uk (institutional) — “the IFS also found that those with PMI are less likely to support increases in public health spending, even when accounting for other characteristics”
Biggest unknown: Whether expanded independent sector use draws NHS staff into private practice faster than it relieves NHS demand — if so, NHS capacity could worsen even as private access improves.
Our reading: The policy has two distinct effects that pull in opposite directions. On the positive side, the independent sector demonstrably offers shorter waits (10.6 vs 17.6 weeks), and a tax relief incentive could shift more patients into that pathway, plausibly reducing NHS waiting lists for elective care. The independent sector already handles meaningful shares of NHS-funded activity in key specialties, so the infrastructure exists to scale. On the negative side, credible institutional analysts — the Nuffield Trust, BMA, Health Foundation, and IPPR — consistently warn that expanding private incentives without a corresponding workforce expansion risks cannibalising the NHS's most constrained resource: staff. Evidence already shows NHS workers moving to the private sector. If this trend accelerates, NHS capacity could deteriorate even as private capacity grows. The independent sector's structural focus on low-complexity cases also means it cannot substitute for NHS capacity in complex or emergency care. Equity is a further concern: tax relief is worth more in absolute terms to higher earners, and the Health Foundation flags that geographic access improvements may be skewed toward wealthier areas. The IFS finding that PMI holders are less likely to support public health spending suggests a longer-run risk of eroding the political coalition for NHS funding. Overall, the verdict is mixed: measurable short-term relief for those who shift to private care is plausible, but the risk of worsening NHS capacity and entrenching inequality is well-evidenced, not merely theoretical. Magnitude is moderate because the policy addresses a real pressure point (waiting times) but also risks feeding a structural problem (workforce diversion) that operates on the same timescale.